Efficacy and Safety of Low-Dose Nab-Paclitaxel Plus Tislelizumab in Elderly Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer

The combination of immunotherapy and chemotherapy has a synergic effect in non-small cell lung cancer (NSCLC). However, the elderly are often excluded from clinical trails due to their poor health status and more comorbidities. We sought to assess the efficacy and safety of low-dose nanoparticle alb...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Wenyu, Geng, Qian, Peng, Haoliang, Jin, Zhihui, Li, Dongqing, Pu, Xiaolin, Wang, Ge, Jiang, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968868/
https://www.ncbi.nlm.nih.gov/pubmed/35372004
http://dx.doi.org/10.3389/fonc.2022.802467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968868/
https://www.ncbi.nlm.nih.gov/pubmed/35372004
http://dx.doi.org/10.3389/fonc.2022.802467

Ejemplares similares